Trials / Completed
CompletedNCT03790033
Efficacy and Safety of Ucha-Shinki-Hwan on Korean Patients With Cold Hypersensitivity in the Hands and Feet-Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 164 (actual)
- Sponsor
- Gachon University Gil Oriental Medical Hospital · Academic / Other
- Sex
- Female
- Age
- 19 Years – 59 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the efficacy and safety of Ucha-Shinki-Hwan on Korean Patients With Cold Hypersensitivity in the Hands and Feet
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ucha-Shinki-Hwan | Product name : Bosinji Granule Manufacturer : Tsumura \& Co. Ingredient : Bosinji granule 2.5g (Bosinji extract 1.523g) Bosinji extract is composed of following proportion of ingredient Rehmannia Root 1.7g Achyranthes Root 1.0g Cornus Fruit 1.0g Dioscorea Rhizome 1.0g Psyllium Husk 1.0g Alisma Rhizome 1.0g Hoelen 1.0g Moutan Root Bark 1.0g Cinnamon Bark 0.3g Pulvis Aconiti Tuberis Purificatum 0.3g |
| DRUG | Placebo | placebo granule |
Timeline
- Start date
- 2018-12-11
- Primary completion
- 2019-08-14
- Completion
- 2019-09-14
- First posted
- 2018-12-31
- Last updated
- 2021-09-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03790033. Inclusion in this directory is not an endorsement.